Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment For Acute Coronary Syndromes Trial
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2600 participants.
Also called NCT01959451
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 2,600 participants
- Sponsor
- Registry
-
NCT01959451
-
- Other papers using this trial's data
- Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Austria, Germany, Hungary, Poland
- Registry status
- Completed
Technical summary
Registry record NCT01959451. Randomized; no masking; primary purpose treatment. Start 2013-09 (registry gives no type); primary completion 2016-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment For Acute Coronary Syndromes Trial
- Acronym
- TROPICAL-ACS
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- Prasugrel
- Intervention (Drug)
- Clopidogrel
- Lead sponsor
- LMU Klinikum
Record details
- Record id
cardio:ct-nct01959451- Content hash
6766ab2b9e8a844d4c78d63094bd8162a306634c9b0feb5216c5051b75b3a547